Skip to main content

Table 5 Regional percent of Aβ deposition per year in a sample of MCI subjects (n = 44, dataset #4)

From: Early detection of amyloid load using 18F-florbetaben PET

  

Percent Aβ deposition per year

Method

Region

Aβ-negative

Gray zone

Established Aβ pathology

MRI-based ROIs

Frontal

− 0.49 ± 2.52 (p = 0.73)

0.85 ± 2.20 (p = 0.19)

1.37 ± 2.02 (p = 0.002)

Lateral temporal

0.15 ± 1.83 (p = 0.40)

0.88 ± 1.58 (p = 0.08)

1.66 ± 1.90 (p < 10−3)

Occipital

0.30 ± 1.64 (p = 0.21)

0.24 ± 1.78 (p = 0.44)

0.94 ± 2.28 (p = 0.055)

Parietal

− 0.48 ± 1.72 (p = 0.87)

1.39 ± 1.23 (p = 0.09)

1.12 ± 1.88 (p = 0.009)

Anterior cingulate

− 0.79 ± 2.49 (p = 0.87)

0.97 ± 0.22 (p = 0.01)

0.76 ± 2.51 (p = 0.08)

Posterior cingulate

0.71 ± 1.41 (p = 0.04)

N.A

1.58 ± 2.26 (p = 0.001)

Precuneus

0.01 ± 1.37 (p = 0.49)

1.24 ± 1.56 (p = 0.11)

1.44 ± 2.31 (p = 0.004)

Composite

− 0.29 ± 1.68 (p = 0.74)

1.51 ± 1.38 (p = 0.04)

1.23 ± 1.90 (p = 0.004)

CL

Cortex

0.08 ± 1.62 (p = 0.43)

2.62 ± 1.47 (p = 0.045)

1.41 ± 1.82 (p = 0.001)

  1. MCI mild cognitive impairment, N.A not available (As Aβ-negative, gray zone, and established Aβ pathology were defined regionally using cutoffs reported in Tables 2 and 3, there were not enough regional standardized uptake values (SUVRs) to calculate percent Aβ deposition per year in some regions), amyloid-beta, MRI magnetic resonance imaging, ROI region of interest, CL centiloid. p-values testing whether percent Aβ deposition per year is significantly larger than zero are given in parenthesis